|
|
||||||||
Journal of Applied Physiology, Vol 76, Issue 4 1753-1758, Copyright © 1994 by American Physiological Society
ARTICLES |
A. Bonen and D. A. Homonko
Department of Kinesiology, University of Waterloo, Ontario, Canada.
In the present study, we investigated the hypotheses that 1) skeletal muscle glyconeogenesis will increase after exercise, 2) greater changes in glyconeogenesis will be observed after exercise in fast-twitch muscles than in slow-twitch muscles, and 3) glycogen repletion will reduce the rates of glyconeogenesis. Mouse soleus and extensor digitorum longus (EDL) glycogen depots were reduced to the same levels by treadmill exercise (60 min) or epinephrine injection (75 micrograms/100 g body wt ip). Untreated animals were used as controls. We were able to prevent glycogen repletion by incubating muscles in vitro with sorbitol (75 mM) and to increase glycogen concentrations in vitro by incubating muscles with glucose (75 mM). The experimental results showed that glyconeogenesis was increased by exercise (EDL, +51%; soleus, +82%) when glycogen levels were kept low. When glycogen depots were increased, the rate of glyconeogenesis was lowered in the exercised EDL (P < 0.05) but not in the soleus (P > 0.05). Reductions in muscle glycogen by epinephrine did not change the rate of glyconeogenesis in EDL, either when glycogen depots were kept low or were repleted (P > 0.05). In contrast, in the soleus, epinephrine-induced reductions in glycogen did stimulate glyconeogenesis (P < 0.05). Analyses in EDL showed that in nonexercised muscles glycogen concentrations were minimally effective in altering the rates of glyconeogenesis. A 30% decrement in glycogen increased glyconeogenesis by 5% in resting muscles, whereas the same decrement increased glyconeogenesis by 51% in exercised muscles.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
A. Bonen, X.-X. Han, D. D. J. Habets, M. Febbraio, J. F. C. Glatz, and J. J. F. P. Luiken A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1740 - E1749. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Enoki, Y. Yoshida, J. Lally, H. Hatta, and A. Bonen Testosterone increases lactate transport, monocarboxylate transporter (MCT) 1 and MCT4 in rat skeletal muscle J. Physiol., November 15, 2006; 577(1): 433 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lerin, E. Montell, T. Nolasco, C. Clark, M. J. Brady, C. B. Newgard, and A. M. Gomez-Foix Regulation and Function of the Muscle Glycogen-Targeting Subunit of Protein Phosphatase 1 (GM) in Human Muscle Cells Depends on the COOH-Terminal Region and Glycogen Content Diabetes, September 1, 2003; 52(9): 2221 - 2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bonen, M. Tonouchi, D. Miskovic, C. Heddle, J. J. Heikkila, and A. P. Halestrap Isoform-specific regulation of the lactate transporters MCT1 and MCT4 by contractile activity Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1131 - E1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Baker, K. J. A. McCullagh, and A. Bonen Training intensity-dependent and tissue-specific increases in lactate uptake and MCT-1 in heart and muscle J Appl Physiol, March 1, 1998; 84(3): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonouchi, H. Hatta, and A. Bonen Muscle contraction increases lactate transport while reducing sarcolemmal MCT4, but not MCT1 Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1062 - E1069. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |